Ohwada N, Nagayama M, Kosuge T, Tsukagoshi T, Ibuki Y, Igarashi M, Yazaki K, Ito T, Nogami Y, Kimura H
College of Medical Care and Technology, Gunma University.
Gan To Kagaku Ryoho. 1992 Nov;19(13):2219-26.
The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer made a comparative study on postoperative supplementary chemotherapy including UFT and FT-E for gynecological malignant tumors. The number of cases registered totaled 182, which was broken down into ovarian cancer 53 cases, uterine cervical cancer 89 cases and endometrial cancer 30 cases. Complete cases among them consisted of ovarian cancer 53 cases, uterine cervical cancer 86 cases and endometrial cancer 27 cases for a total of 166 cases. Ovarian cancer was stratified into the completely and incompletely removed cases, uterine cervical cancer into postoperative non-irradiated and irradiated cases and endometrial cancer into the positive metastasis (+) group and negative metastasis (-) group. Then the UFT administration group and FT-E administration group were compared for postoperative survival. There were control groups for both ovarian and endometrial cancer. UFT administration showed a significant improvement in the survival rate (P < 0.05) compared to the FT-E administration group in the cases of ovarian cancer completely removed and the cases of endometrial cancer irradiated after operation. No significant difference was observed between other groups compared. The incidence of side effects was 20.6% (20/97) in the UFT administration group and 3.6% (2/55) in the FT-E group. Neither group showed any serious side effects.
群马县妇科癌症化疗研究协会对包括优福定(UFT)和替加氟-尿嘧啶复方制剂(FT-E)在内的妇科恶性肿瘤术后辅助化疗进行了比较研究。登记病例总数为182例,其中卵巢癌53例,子宫颈癌89例,子宫内膜癌30例。其中完整病例包括卵巢癌53例,子宫颈癌86例,子宫内膜癌27例,共计166例。卵巢癌分为完全切除和不完全切除病例,子宫颈癌分为术后未放疗和已放疗病例,子宫内膜癌分为阳性转移(+)组和阴性转移(-)组。然后比较优福定给药组和替加氟-尿嘧啶复方制剂给药组的术后生存率。卵巢癌和子宫内膜癌均设有对照组。在卵巢癌完全切除病例和术后放疗的子宫内膜癌病例中,与替加氟-尿嘧啶复方制剂给药组相比,优福定给药组的生存率有显著提高(P < 0.05)。其他组之间未观察到显著差异。优福定给药组的副作用发生率为20.6%(20/97),替加氟-尿嘧啶复方制剂组为3.6%(2/55)。两组均未出现任何严重副作用。